Press Release: UFP Technologies to Report Second Quarter 2026 Financial Results on August 3, 2026

Dow Jones
Jul 30

Conference Call Scheduled for August 4(th) at 8:30 AM ET

NEWBURYPORT, Mass.--(BUSINESS WIRE)--July 29, 2026-- 

UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the second quarter on Monday, August 3(rd) , after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, August 4(th) , at 8:30 AM Eastern time.

Conference Call Information:

Date: Tuesday, August 4, 2026

Time: 8:30 AM Eastern Time

Participants may join the call using the following dial-in numbers:

   --  USA/Canada: Toll-Free: 1-412-206-6478 
 
   --  International: 1-833-890-4010 

A live webcast of the conference call and accompanying materials will be available here.

A replay of the webcast will be accessible following the event on the Company's Investor Relations website at https://ufpt.com/investors/.

About UFP Technologies, Inc.

UFP Technologies is a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products. The company's single-use and single-patient devices and components are used across a wide range of medical products in segments including robotic assisted surgery, patient beds, infection control, cardiovascular, orthopedics and spine and wound care. For more information, visit ufpt.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260729601845/en/

 
    CONTACT:    Investor Contact: 

Jeff Elliott

Three Part Advisors, LLC

214-966-9014

UFP Technologies Contact:

Ron Lataille, CFO

978-234-0926

rlataille@ufpt.com

 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10